Cargando…

Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy

BACKGROUND AND PURPOSE: The modified systemic inflammation score (mSIS) system, which is constructed based on the neutrophil to lymphocyte ratio (NLR) and albumin (Alb), has not been applied to evaluate the prognosis of malignant breast cancer patients who underwent neoadjuvant chemotherapy (NAC). T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Cong, Xiu, Yuting, Yu, Xiao, Qiao, Kun, Zhang, Shiyuan, Huang, Yuanxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717545/ https://www.ncbi.nlm.nih.gov/pubmed/36460981 http://dx.doi.org/10.1186/s12885-022-10291-2

Ejemplares similares

A Novel Inflammatory and Nutritional Prognostic Scoring System for Nonpathological Complete Response Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Jiang, Cong, et al.
Publicado: (2022)

Systemic Immune-Inflammation Index Is Superior to Neutrophil to Lymphocyte Ratio in Prognostic Assessment of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Jiang, Cong, et al.
Publicado: (2020)

Prediction of lymph node metastasis in patients with breast invasive micropapillary carcinoma based on machine learning and SHapley Additive exPlanations framework
por: Jiang, Cong, et al.
Publicado: (2022)

Prediction of nonsentinel lymph node metastasis in breast cancer patients based on machine learning
por: Xiu, Yuting, et al.
Publicado: (2023)

Prognostic value of selected preoperative inflammation-based scores in patients with high-risk localized prostate cancer who underwent radical prostatectomy
por: Shu, Kunpeng, et al.
Publicado: (2018)

Association of PTP1B with Outcomes of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
por: Rivera Franco, Monica M., et al.
Publicado: (2016)

The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
por: Morkavuk, Şevket Barış, et al.
Publicado: (2021)

Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases
por: Liao, Leen, et al.
Publicado: (2023)

The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
por: Lee, Janghee, et al.
Publicado: (2021)

Feasibility research of enhanced recovery after surgery implemented in esophageal cancer patients who underwent neoadjuvant chemotherapy
por: Tang, Zhanpeng, et al.
Publicado: (2022)

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
por: Lee, So Heun, et al.
Publicado: (2023)

Comparison of the prognostic value of SYNTAX score and clinical SYNTAX score on outcomes of Chinese patients underwent percutaneous coronary intervention
por: Li, Xiao-Qin, et al.
Publicado: (2021)

The Usefulness of Inflammation-based Prognostic Scores for the Prediction of Postoperative Mortality in Patients Who Underwent Intestinal Resection for Acute Intestinal Ischemia
por: Vural, Veli, et al.
Publicado: (2019)

Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy
por: Tang, Xiaolong, et al.
Publicado: (2019)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
por: Zheng, Chen, et al.
Publicado: (2023)

A Pre-Operative Prognostic Score for Patients With Advanced Hepatocellular Carcinoma Who Underwent Resection
por: Xiao, Han, et al.
Publicado: (2021)

Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
por: Cho, Yeona, et al.
Publicado: (2018)

Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection
por: Wu, Wenlong, et al.
Publicado: (2021)

Prognostic factors in patients with thymoma who underwent surgery
por: Jiang, Yu-Gang, et al.
Publicado: (2023)

Added value of systemic inflammation markers for monitoring response to neoadjuvant chemotherapy in breast cancer patients
por: Ke, Zi-Rui, et al.
Publicado: (2022)

Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy
por: Kim, Hong Jun, et al.
Publicado: (2020)

Effect of neoadjuvant chemotherapy on survival in patients with T1 high-grade non-muscle-invasive bladder cancer who underwent radical cystectomy
por: Huang, Long, et al.
Publicado: (2023)

Modified Colon Leakage Score to Predict Anastomotic Leakage in Patients Who Underwent Left-Sided Colorectal Surgery
por: Yang, Seung Up, et al.
Publicado: (2019)

Prognostic Value of Preoperative Serum Leucine Aminopeptidases in Hepatocellular Carcinoma Patients Who Underwent Liver Transplantation
por: Ren, Qingqi, et al.
Publicado: (2021)

Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy
por: Robl, Bernhard, et al.
Publicado: (2015)

Prognostic value of final pathological stage in colon adenocarcinoma after neoadjuvant chemotherapy: A propensity score-matched study
por: Xiang, Meijuan, et al.
Publicado: (2022)

Predictive Value of Gensini Score in the Long-Term Outcomes of Patients With Coronary Artery Disease Who Underwent PCI
por: Wang, Kai-Yang, et al.
Publicado: (2022)

Collagenous Colitis in a Patient With Gastric Cancer Who Underwent Chemotherapy
por: Iwamuro, Masaya, et al.
Publicado: (2023)

Prognostic Significance of Preoperative Controlling Nutritional Status Score in Patients Who Underwent Hepatic Resection for Hepatocellular Carcinoma
por: Kim, Bum-Soo
Publicado: (2020)

The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
por: Jomrich, Gerd, et al.
Publicado: (2018)

Application value of nomogram and prognostic factors of gastric cancer patients who underwent D2 radical lymphadenectomy
por: Mu, Guang-Chuan, et al.
Publicado: (2019)

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
por: Cao, Maria D, et al.
Publicado: (2012)

Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy
por: Ma, Youzhao, et al.
Publicado: (2023)

Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial
por: Wang, Hao, et al.
Publicado: (2021)

Prognostic Value of the Modified Systemic Inﬂammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma
por: Huang, He, et al.
Publicado: (2020)

Prognostic factors for elderly gastric cancer patients who underwent gastrectomy
por: Endo, Shunji, et al.
Publicado: (2022)

Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?
por: Alan, Ozkan, et al.
Publicado: (2020)

Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection without preoperative neoadjuvant treatment: A systematic review and meta-analysis
por: Zhao, Pengcheng, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
por: Liontos, M., et al.
Publicado: (2021)

Estrogen Receptor and Claudin-6 Might Play Vital Roles for Long-Term Prognosis in Patients With Luminal A Breast Cancer Who Underwent Neoadjuvant Chemotherapy
por: Liu, Yushi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v74uib7r9cbc3tm4asntng3n0s